跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Halogenated xanthene
首页
药物
Halogenated xanthene
Halogenated xanthene
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Intracorporeal medicaments for photodynamic treatment of disease
US 7390668 B2
申请人: PROVECTUS PHARMATECH INC
优先权: 2000
CN
EP
US
WO
12 件公开
A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER
EP 2710137 B1
申请人: PROVECTUS PHARMATECH INC
优先权: 2011
CN
EP
US
WO
12 件公开
TREATMENT OF SOLID CANCEROUS TUMORS BY ORAL ADMINISTRATION OF A HALOGENATED XANTHENE
EP 4106814 A4
申请人: PROVECTUS PHARMATECH INC
优先权: 2020
CN
EP
US
WO
12 件公开
IN VITRO AND XENOGRAFT ANTI-TUMOR ACTIVITY OF A HALOGENATED-XANTHENE AGAINST REFRACTORY PEDIATRIC SOLID TUMORS
EP 3773548 B1
申请人: PROVECTUS PHARMATECH INC
优先权: 2018
CN
EP
US
WO
10 件公开
INTRACORPOREAL MEDICAMENTS FOR HIGH ENERGY PHOTOTHERAPEUTIC TREATMENT OF DISEASE
EP 1292298 B1
申请人: PHOTOGEN INC
优先权: 2000
EP
US
WO
6 件公开
US 8470296 B2
申请人: DEES H CRAIG
优先权: 2007
US
2 件公开
US 2010076246 A1
申请人: PROVECTUS PHARMATECH INC
优先权: 2009
US
COMBINATION OF LOCAL AND SYSTEMIC THERAPIES FOR ENHANCED TREATMENT OF DERMATOLOGIC CONDITIONS
EP 3700520 C0
申请人: UNIV ROCKEFELLER
优先权: 2017
CN
EP
US
WO
5 件公开
IMPROVED TOPICAL MEDICAMENTS AND METHODS FOR PHOTODYNAMIC TREATMENT OF DISEASE
EP 1210078 B1
申请人: PROVECTUS PHARMATECH INC
优先权: 1999
CN
EP
WO
5 件公开
Medicaments for chemotherapeutic treatment of disease
US 7648695 B2
申请人: PROVECTUS PHARMATECH INC
优先权: 2000
EP
US
WO
5 件公开
US 2008118567 A1
申请人: PROVECTUS PHARMATECH INC
优先权: 2007
US
2 件公开
METHOD OF EX VIVO ENHANCEMENT OF IMMUNE CELL ACTIVITY FOR CANCER IMMUNOTHERAPY WITH A SMALL MOLECULE ABLATIVE COMPOUND
EP 3347041 A1
申请人: PROVECTUS PHARMATECH INC
优先权: 2015
EP
US
WO
5 件公开
Ultrasound contrast using halogenated xanthenes
US 6986740 B2
申请人: XANTECH PHARMACEUTICALS INC
优先权: 2002
EP
US
4 件公开
第 1 / 3 页
上一页
下一页
药物
反馈